ONTOLOGY REPORT - ANNOTATIONS
| Term: | rosiglitazone |
|
| Accession: | CHEBI:50122
|
browse the term
|
| Definition: | A thiazolidenedione that has formula C18H19N3O3S. |
| Synonyms: | exact_synonym: | 5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione |
| | related_synonym: | 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione; BRL-49653; C18H19N3O3S; CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1; InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23); InChIKey=YASAKCUCGLMORW-UHFFFAOYSA-N; rosiglitazona; rosiglitazonum |
| | xref_casrn: | 122320-73-4 |
| | xref: | Beilstein:7082202 "Beilstein Registry Number"; ChEMBL:120027 "ChEMBL COMPOUND"; ChemIDplus:122320-73-4 "CAS Registry Number"; DrugBank:DB00412 "DrugBank" |
| | xref_mesh: | MESH:C089730 |
| | xref: | Patent:EP306228 "Patent"; Patent:US5002953 "Patent"; Wikipedia:Rosiglitazone "Wikipedia" |
|
|
rosiglitazone
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc9 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 9 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc9 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 9 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
multiple interactions |
ISO |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
increases expression |
ISO |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Abhd11 |
abhydrolase domain containing 11 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
increases expression |
ISO |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
affects expression |
ISO |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
affects expression |
ISO |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
increases expression |
ISO |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
increases expression |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
increases expression |
ISO |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
increases expression |
ISO |
9 |
65,613,130 |
65,651,775 |
RGD:6480464 |
CTD |
| G |
Acads |
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
|
increases expression |
ISO |
12 |
42,765,284 |
42,774,528 |
RGD:6480464 |
CTD |
| G |
Acadsb |
acyl-CoA dehydrogenase, short/branched chain |
|
increases expression |
ISO |
1 |
190,987,657 |
191,026,275 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases expression |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases expression |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases expression |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
increases expression |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
increases expression |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Acot7 |
acyl-CoA thioesterase 7 |
|
affects expression |
ISO |
5 |
169,409,306 |
169,501,907 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
multiple interactions |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
increases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
increases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
multiple interactions |
ISO |
X |
36,168,547 |
36,232,162 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
multiple interactions |
ISO |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
multiple interactions |
ISO |
3 |
99,901,022 |
99,906,558 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
multiple interactions |
ISO |
4 |
117,732,482 |
117,747,006 |
RGD:6480464 |
CTD |
| G |
Ada |
adenosine deaminase |
|
increases expression |
ISO |
3 |
154,636,530 |
154,660,637 |
RGD:6480464 |
CTD |
| G |
Adam12 |
ADAM metallopeptidase domain 12 |
|
multiple interactions |
ISO |
1 |
193,384,457 |
193,650,892 |
RGD:6480464 |
CTD |
| G |
Adam9 |
ADAM metallopeptidase domain 9 |
|
multiple interactions |
ISO |
16 |
71,446,498 |
71,526,108 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
multiple interactions |
ISO |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
increases expression |
EXP |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
affects response to substance |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases secretion |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
decreases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipor1 |
adiponectin receptor 1 |
|
multiple interactions |
ISO |
13 |
47,358,625 |
47,379,565 |
RGD:6480464 |
CTD |
| G |
Adipor1 |
adiponectin receptor 1 |
|
multiple interactions |
EXP |
13 |
47,358,625 |
47,379,565 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
increases expression |
ISO |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
multiple interactions |
ISO |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
increases activity |
ISO |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
increases expression |
ISO |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
multiple interactions |
ISO |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
increases expression |
ISO |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
multiple interactions |
EXP |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
multiple interactions |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
multiple interactions |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
decreases expression |
ISO |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Agpat4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
|
increases expression |
ISO |
1 |
42,986,809 |
43,096,390 |
RGD:6480464 |
CTD |
| G |
Agpat9 |
1-acylglycerol-3-phosphate O-acyltransferase 9 |
|
increases expression |
EXP |
14 |
9,998,566 |
10,050,154 |
RGD:6480464 |
CTD |
| G |
Agrn |
agrin |
|
decreases expression |
ISO |
5 |
172,999,420 |
173,020,764 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
multiple interactions |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ajuba |
ajuba LIM protein |
|
multiple interactions |
ISO |
15 |
32,627,633 |
32,637,861 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
multiple interactions |
ISO |
1 |
34,979,039 |
35,068,763 |
RGD:6480464 |
CTD |
| G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
|
increases expression |
ISO |
8 |
75,692,099 |
75,771,159 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
increases expression |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Amotl2 |
angiomotin like 2 |
|
multiple interactions |
ISO |
8 |
107,694,405 |
107,709,841 |
RGD:6480464 |
CTD |
| G |
Angptl2 |
angiopoietin-like 2 |
|
multiple interactions |
ISO |
3 |
12,226,515 |
12,256,396 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
multiple interactions |
ISO |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
increases expression |
ISO |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Ankrd37 |
ankyrin repeat domain 37 |
|
multiple interactions |
ISO |
16 |
49,549,527 |
49,552,416 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
multiple interactions |
ISO |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Anxa6 |
annexin A6 |
|
multiple interactions |
ISO |
10 |
40,383,975 |
40,439,683 |
RGD:6480464 |
CTD |
| G |
Apcdd1 |
adenomatosis polyposis coli down-regulated 1 |
|
multiple interactions |
ISO |
18 |
59,088,709 |
59,091,205 |
RGD:6480464 |
CTD |
| G |
Aplp2 |
amyloid beta (A4) precursor-like protein 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
multiple interactions |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp8 |
aquaporin 8 |
|
increases expression |
ISO |
1 |
182,331,494 |
182,337,291 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
increases expression |
ISO |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arhgap5 |
Rho GTPase activating protein 5 |
|
multiple interactions |
ISO |
6 |
72,685,231 |
72,693,052 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
multiple interactions |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
decreases expression |
ISO |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp5o |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
affects expression |
ISO |
11 |
31,914,320 |
31,920,632 |
RGD:6480464 |
CTD |
| G |
B3gnt4 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 |
|
increases expression |
ISO |
12 |
34,209,650 |
34,211,063 |
RGD:6480464 |
CTD |
| G |
Bag2 |
Bcl2-associated athanogene 2 |
|
increases expression |
ISO |
9 |
32,491,167 |
32,493,678 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
increases expression |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
affects expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
decreases expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
decreases expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
affects expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
decreases expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
affects expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bgn |
biglycan |
|
increases expression |
EXP |
X |
159,380,557 |
159,393,409 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bmi1 |
Bmi1 polycomb ring finger oncogene |
|
decreases expression |
ISO |
17 |
92,784,216 |
92,787,947 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
|
multiple interactions |
ISO |
9 |
57,053,423 |
57,065,699 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Calcrl |
calcitonin receptor-like |
|
decreases expression |
ISO |
3 |
67,553,022 |
67,646,877 |
RGD:6480464 |
CTD |
| G |
Calml4 |
calmodulin-like 4 |
|
multiple interactions |
ISO |
8 |
67,007,122 |
67,018,886 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav2 |
caveolin 2 |
|
multiple interactions |
ISO |
4 |
42,932,127 |
42,939,503 |
RGD:6480464 |
CTD |
| G |
Cav2 |
caveolin 2 |
|
increases expression |
ISO |
4 |
42,932,127 |
42,939,503 |
RGD:6480464 |
CTD |
| G |
Cbr3 |
carbonyl reductase 3 |
|
affects expression |
ISO |
11 |
33,913,961 |
33,922,221 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
multiple interactions |
ISO |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
multiple interactions |
ISO |
19 |
10,641,376 |
10,642,827 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
decreases response to substance |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
multiple interactions |
ISO |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
decreases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccr7 |
chemokine (C-C motif) receptor 7 |
|
decreases expression |
ISO |
10 |
87,925,093 |
87,936,325 |
RGD:6480464 |
CTD |
| G |
Cd1d1 |
CD1d1 molecule |
|
increases expression |
ISO |
2 |
179,011,165 |
179,014,672 |
RGD:6480464 |
CTD |
| G |
Cd300lb |
CD300 molecule-like family member b |
|
increases expression |
ISO |
10 |
104,825,709 |
104,835,698 |
RGD:6480464 |
CTD |
| G |
Cd300lf |
Cd300 molecule-like family member F |
|
increases expression |
ISO |
10 |
105,192,308 |
105,209,016 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
affects expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions |
EXP |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
multiple interactions |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
decreases expression |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
multiple interactions |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
multiple interactions |
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
multiple interactions |
ISO |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
multiple interactions |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
multiple interactions |
ISO |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Cdr2l |
cerebellar degeneration-related protein 2-like |
|
decreases expression |
ISO |
10 |
105,460,482 |
105,472,167 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
increases expression |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Celf2 |
CUGBP, Elav-like family member 2 |
|
multiple interactions |
ISO |
17 |
82,708,354 |
83,025,139 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
increases expression |
ISO |
7 |
11,325,538 |
11,327,261 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
decreases expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
decreases expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
multiple interactions |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
decreases expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
multiple interactions |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
multiple interactions |
ISO |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
decreases expression |
ISO |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
multiple interactions |
ISO |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
increases expression |
ISO |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Cidec |
cell death-inducing DFFA-like effector c |
|
increases expression |
ISO |
4 |
149,307,986 |
149,321,303 |
RGD:6480464 |
CTD |
| G |
Cidec |
cell death-inducing DFFA-like effector c |
|
increases expression |
EXP |
4 |
149,307,986 |
149,321,303 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
affects expression |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Cog8 |
component of oligomeric golgi complex 8 |
|
multiple interactions |
ISO |
19 |
36,904,222 |
36,914,972 |
RGD:6480464 |
CTD |
| G |
Col11a1 |
collagen, type XI, alpha 1 |
|
multiple interactions |
ISO |
2 |
209,996,467 |
210,193,379 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
multiple interactions |
ISO |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col5a3 |
collagen, type V, alpha 3 |
|
increases expression |
ISO |
8 |
19,789,061 |
19,834,241 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
multiple interactions |
ISO |
9 |
89,990,129 |
90,043,697 |
RGD:6480464 |
CTD |
| G |
Commd5 |
COMM domain containing 5 |
|
increases expression |
ISO |
7 |
114,949,725 |
114,951,149 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
affects expression |
ISO |
9 |
35,625,478 |
35,627,304 |
RGD:6480464 |
CTD |
| G |
Cox7c |
cytochrome c oxidase, subunit VIIc |
|
affects expression |
ISO |
2 |
15,254,040 |
15,256,065 |
RGD:6480464 |
CTD |
| G |
Cox8b |
cytochrome c oxidase, subunit VIIIb |
|
increases expression |
ISO |
1 |
201,057,314 |
201,058,769 |
RGD:6480464 |
CTD |
| G |
Cox8b |
cytochrome c oxidase, subunit VIIIb |
|
multiple interactions |
ISO |
1 |
201,057,314 |
201,058,769 |
RGD:6480464 |
CTD |
| G |
Cox8b |
cytochrome c oxidase, subunit VIIIb |
|
increases expression |
ISO |
1 |
201,057,314 |
201,058,769 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
multiple interactions |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
multiple interactions |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
increases expression |
ISO |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
increases expression |
ISO |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
multiple interactions |
ISO |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
increases expression |
ISO |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
multiple interactions |
EXP |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Cpt2 |
carnitine palmitoyltransferase 2 |
|
affects expression |
ISO |
5 |
129,007,685 |
129,025,501 |
RGD:6480464 |
CTD |
| G |
Crat |
carnitine O-acetyltransferase |
|
increases expression |
ISO |
3 |
9,447,585 |
9,461,180 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
decreases phosphorylation |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Crkl |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
multiple interactions |
ISO |
11 |
85,520,244 |
85,554,667 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
decreases expression |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
decreases expression |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
multiple interactions |
ISO |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Cs |
citrate synthase |
|
increases expression |
ISO |
7 |
1,626,181 |
1,652,197 |
RGD:6480464 |
CTD |
| G |
Cs |
citrate synthase |
|
increases expression |
ISO |
7 |
1,626,181 |
1,652,197 |
RGD:6480464 |
CTD |
| G |
Cs |
citrate synthase |
|
increases expression |
EXP |
7 |
1,626,181 |
1,652,197 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
ISO |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Csn2 |
casein beta |
|
increases expression |
ISO |
14 |
21,847,981 |
21,855,216 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cttnbp2 |
cortactin binding protein 2 |
|
decreases expression |
ISO |
4 |
44,114,097 |
44,277,748 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
multiple interactions |
ISO |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
affects localization |
ISO |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
|
affects localization |
ISO |
8 |
125,033,630 |
125,047,335 |
RGD:6480464 |
CTD |
| G |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
|
decreases expression |
ISO |
8 |
125,033,630 |
125,047,335 |
RGD:6480464 |
CTD |
| G |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
|
multiple interactions |
ISO |
8 |
125,033,630 |
125,047,335 |
RGD:6480464 |
CTD |
| G |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
|
decreases expression |
ISO |
8 |
125,033,630 |
125,047,335 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases response to substance |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
multiple interactions |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
increases expression |
EXP |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
multiple interactions |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
multiple interactions |
ISO |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
increases expression |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
increases expression |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
|
increases metabolic processing |
ISO |
1 |
244,400,004 |
244,493,624 |
RGD:6480464 |
CTD |
| G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
|
decreases activity |
ISO |
1 |
244,400,004 |
244,493,624 |
RGD:6480464 |
CTD |
| G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
|
decreases metabolic processing |
ISO |
1 |
244,400,004 |
244,493,624 |
RGD:6480464 |
CTD |
| G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
|
affects metabolic processing |
ISO |
1 |
244,400,004 |
244,493,624 |
RGD:6480464 |
CTD |
| G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
|
increases metabolic processing |
ISO |
1 |
244,400,004 |
244,493,624 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
decreases activity |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
decreases activity |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
multiple interactions |
ISO |
7 |
35,004,234 |
35,045,191 |
RGD:6480464 |
CTD |
| G |
Dcstamp |
dendrocyte expressed seven transmembrane protein |
|
increases expression |
ISO |
7 |
75,318,788 |
75,336,382 |
RGD:6480464 |
CTD |
| G |
Decr1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
|
increases expression |
ISO |
5 |
30,492,196 |
30,520,172 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
multiple interactions |
ISO |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
decreases expression |
ISO |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
increases expression |
EXP |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
multiple interactions |
ISO |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
increases expression |
EXP |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
decreases expression |
ISO |
1 |
156,447,588 |
156,478,740 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
increases expression |
ISO |
1 |
156,447,588 |
156,478,740 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
decreases expression |
ISO |
1 |
156,447,588 |
156,478,740 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
increases expression |
EXP |
1 |
156,447,588 |
156,478,740 |
RGD:6480464 |
CTD |
| G |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
|
increases expression |
ISO |
5 |
163,341,856 |
163,375,604 |
RGD:6480464 |
CTD |
| G |
Dhrs9 |
dehydrogenase/reductase (SDR family) member 9 |
|
increases expression |
ISO |
3 |
51,521,343 |
51,543,552 |
RGD:6480464 |
CTD |
| G |
Dld |
dihydrolipoamide dehydrogenase |
|
increases expression |
ISO |
6 |
49,185,188 |
49,205,894 |
RGD:6480464 |
CTD |
| G |
Dld |
dihydrolipoamide dehydrogenase |
|
affects expression |
ISO |
6 |
49,185,188 |
49,205,894 |
RGD:6480464 |
CTD |
| G |
Dlg1 |
discs, large homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
11 |
70,735,283 |
70,930,374 |
RGD:6480464 |
CTD |
| G |
Dmpk |
dystrophia myotonica-protein kinase |
|
decreases expression |
ISO |
1 |
78,449,324 |
78,450,578 |
RGD:6480464 |
CTD |
| G |
Dmwd |
dystrophia myotonica, WD repeat containing |
|
decreases expression |
ISO |
1 |
78,432,701 |
78,439,057 |
RGD:6480464 |
CTD |
| G |
Dnaaf2 |
dynein, axonemal, assembly factor 2 |
|
multiple interactions |
ISO |
6 |
91,142,003 |
91,149,874 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
multiple interactions |
ISO |
6 |
63,583,033 |
63,587,247 |
RGD:6480464 |
CTD |
| G |
Dnajc5b |
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
|
increases expression |
ISO |
2 |
104,595,007 |
104,687,531 |
RGD:6480464 |
CTD |
| G |
Dusp10 |
dual specificity phosphatase 10 |
|
multiple interactions |
ISO |
13 |
100,022,421 |
100,059,539 |
RGD:6480464 |
CTD |
| G |
E2f4 |
E2F transcription factor 4, p107/p130-binding |
|
decreases expression |
ISO |
19 |
35,112,273 |
35,118,888 |
RGD:6480464 |
CTD |
| G |
Ece1 |
endothelin converting enzyme 1 |
|
multiple interactions |
ISO |
5 |
156,635,656 |
156,735,783 |
RGD:6480464 |
CTD |
| G |
Eci1 |
enoyl-CoA delta isomerase 1 |
|
affects expression |
ISO |
10 |
13,683,000 |
13,697,179 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
multiple interactions |
ISO |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases expression |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
multiple interactions |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases expression |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
multiple interactions |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
increases expression |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Ehf |
ets homologous factor |
|
increases expression |
ISO |
3 |
88,518,893 |
88,557,065 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif5a |
eukaryotic translation initiation factor 5A |
|
increases expression |
ISO |
10 |
56,760,289 |
56,764,689 |
RGD:6480464 |
CTD |
| G |
Eln |
elastin |
|
increases expression |
EXP |
12 |
23,033,657 |
23,077,043 |
RGD:6480464 |
CTD |
| G |
Elovl3 |
ELOVL fatty acid elongase 3 |
|
multiple interactions |
ISO |
1 |
251,351,908 |
251,355,736 |
RGD:6480464 |
CTD |
| G |
Elovl3 |
ELOVL fatty acid elongase 3 |
|
increases expression |
ISO |
1 |
251,351,908 |
251,355,736 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
multiple interactions |
ISO |
2 |
226,946,573 |
227,054,321 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
increases expression |
EXP |
2 |
226,946,573 |
227,054,321 |
RGD:6480464 |
CTD |
| G |
Emb |
embigin |
|
multiple interactions |
ISO |
2 |
49,098,743 |
49,155,221 |
RGD:6480464 |
CTD |
| G |
Eml4 |
echinoderm microtubule associated protein like 4 |
|
increases expression |
ISO |
6 |
6,754,664 |
6,813,231 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
multiple interactions |
ISO |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Eno3 |
enolase 3, beta, muscle |
|
affects expression |
ISO |
10 |
57,536,965 |
57,542,317 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
multiple interactions |
ISO |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
multiple interactions |
ISO |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
increases expression |
ISO |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Etfa |
electron-transfer-flavoprotein, alpha polypeptide |
|
increases expression |
ISO |
8 |
59,013,798 |
59,072,013 |
RGD:6480464 |
CTD |
| G |
Etfb |
electron-transfer-flavoprotein, beta polypeptide |
|
increases expression |
ISO |
1 |
93,820,124 |
93,834,288 |
RGD:6480464 |
CTD |
| G |
Etfdh |
electron-transferring-flavoprotein dehydrogenase |
|
increases expression |
ISO |
2 |
171,008,641 |
171,030,692 |
RGD:6480464 |
CTD |
| G |
Ets2 |
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
|
increases expression |
ISO |
11 |
36,014,047 |
36,030,833 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
increases expression |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
EXP |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
EXP |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fam101b |
family with sequence similarity 101, member B |
|
increases expression |
ISO |
10 |
63,384,402 |
63,390,679 |
RGD:6480464 |
CTD |
| G |
Fam109a |
family with sequence similarity 109, member A |
|
decreases expression |
ISO |
12 |
35,917,800 |
35,921,702 |
RGD:6480464 |
CTD |
| G |
Fam210a |
family with sequence similarity 210, member A |
|
multiple interactions |
ISO |
18 |
64,711,764 |
64,752,197 |
RGD:6480464 |
CTD |
| G |
Far2 |
fatty acyl CoA reductase 2 |
|
increases expression |
ISO |
4 |
185,758,904 |
185,791,596 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
EXP |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fbn2 |
fibrillin 2 |
|
multiple interactions |
ISO |
18 |
53,883,011 |
53,914,001 |
RGD:6480464 |
CTD |
| G |
Fbxo15 |
F-box protein 15 |
|
increases expression |
ISO |
18 |
81,542,665 |
81,599,809 |
RGD:6480464 |
CTD |
| G |
Fbxo32 |
F-box protein 32 |
|
decreases expression |
EXP |
7 |
94,909,568 |
94,942,444 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
multiple interactions |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
multiple interactions |
ISO |
8 |
55,291,396 |
55,310,507 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
multiple interactions |
ISO |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
multiple interactions |
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Figf |
c-fos induced growth factor |
|
multiple interactions |
ISO |
X |
50,830,612 |
50,864,445 |
RGD:6480464 |
CTD |
| G |
Fjx1 |
four jointed box 1 (Drosophila) |
|
multiple interactions |
ISO |
3 |
87,640,138 |
87,642,239 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
multiple interactions |
ISO |
20 |
6,637,478 |
6,686,768 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
multiple interactions |
ISO |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo3 |
flavin containing monooxygenase 3 |
|
multiple interactions |
ISO |
13 |
78,659,513 |
78,678,524 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
EXP |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Fut7 |
fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
|
decreases expression |
ISO |
3 |
3,590,174 |
3,593,046 |
RGD:6480464 |
CTD |
| G |
Fzd2 |
frizzled family receptor 2 |
|
multiple interactions |
ISO |
10 |
91,709,222 |
91,711,132 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
multiple interactions |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
GABA(A) receptor-associated protein like 1 |
|
increases expression |
ISO |
4 |
166,802,106 |
166,811,249 |
RGD:6480464 |
CTD |
| G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
|
multiple interactions |
ISO |
17 |
19,230,896 |
19,232,641 |
RGD:6480464 |
CTD |
| G |
Galk1 |
galactokinase 1 |
|
multiple interactions |
ISO |
10 |
106,116,774 |
106,120,951 |
RGD:6480464 |
CTD |
| G |
Gas2 |
growth arrest-specific 2 |
|
multiple interactions |
ISO |
1 |
101,697,265 |
101,798,495 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
multiple interactions |
ISO |
16 |
80,900,159 |
80,930,929 |
RGD:6480464 |
CTD |
| G |
Gbp2 |
guanylate binding protein 2, interferon-inducible |
|
multiple interactions |
ISO |
2 |
240,523,000 |
240,541,078 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
multiple interactions |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gem |
GTP binding protein overexpressed in skeletal muscle |
|
multiple interactions |
ISO |
5 |
25,809,543 |
26,008,249 |
RGD:6480464 |
CTD |
| G |
Gemin4 |
gem (nuclear organelle) associated protein 4 |
|
multiple interactions |
ISO |
10 |
63,564,269 |
63,571,193 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gk |
glycerol kinase |
|
increases expression |
EXP |
X |
72,416,872 |
72,493,296 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
multiple interactions |
ISO |
8 |
112,861,952 |
112,882,647 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
increases expression |
EXP |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
multiple interactions |
ISO |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpc1 |
glypican 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpd1l |
glycerol-3-phosphate dehydrogenase 1-like |
|
decreases expression |
ISO |
8 |
119,317,528 |
119,347,194 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
multiple interactions |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
multiple interactions |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
multiple interactions |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gucy1b3 |
guanylate cyclase 1, soluble, beta 3 |
|
multiple interactions |
ISO |
2 |
173,683,153 |
173,735,298 |
RGD:6480464 |
CTD |
| G |
Gusb |
glucuronidase, beta |
|
increases expression |
ISO |
12 |
27,744,409 |
27,757,755 |
RGD:6480464 |
CTD |
| G |
Gyg1 |
glycogenin 1 |
|
increases expression |
EXP |
2 |
105,264,657 |
105,307,070 |
RGD:6480464 |
CTD |
| G |
Gys2 |
glycogen synthase 2 |
|
increases expression |
ISO |
4 |
179,984,036 |
180,018,819 |
RGD:6480464 |
CTD |
| G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
|
increases expression |
ISO |
2 |
228,698,545 |
228,751,691 |
RGD:6480464 |
CTD |
| G |
Hilpda |
hypoxia inducible lipid droplet-associated |
|
multiple interactions |
ISO |
4 |
56,146,654 |
56,147,441 |
RGD:6480464 |
CTD |
| G |
Hipk2 |
homeodomain interacting protein kinase 2 |
|
increases expression |
ISO |
4 |
66,273,623 |
66,455,774 |
RGD:6480464 |
CTD |
| G |
Hist1h2bd |
histone cluster 1, H2bd |
|
decreases expression |
ISO |
17 |
50,429,266 |
50,429,647 |
RGD:6480464 |
CTD |
| G |
Hk2 |
hexokinase 2 |
|
multiple interactions |
ISO |
4 |
116,925,725 |
116,975,211 |
RGD:6480464 |
CTD |
| G |
Hlx |
H2.0-like homeobox |
|
decreases expression |
ISO |
13 |
100,685,757 |
100,691,658 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions |
ISO |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
decreases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox2 |
heme oxygenase (decycling) 2 |
|
multiple interactions |
ISO |
10 |
10,914,157 |
10,929,448 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
multiple interactions |
EXP |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hnrpdl |
heterogeneous nuclear ribonucleoprotein D-like |
|
multiple interactions |
ISO |
14 |
10,861,054 |
10,864,322 |
RGD:6480464 |
CTD |
| G |
Hp |
haptoglobin |
|
multiple interactions |
ISO |
19 |
39,443,016 |
39,447,566 |
RGD:6480464 |
CTD |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
multiple interactions |
ISO |
13 |
109,063,491 |
109,089,468 |
RGD:6480464 |
CTD |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
affects expression |
ISO |
13 |
109,063,491 |
109,089,468 |
RGD:6480464 |
CTD |
| G |
Hsd17b12 |
hydroxysteroid (17-beta) dehydrogenase 12 |
|
affects expression |
ISO |
3 |
78,436,634 |
78,559,707 |
RGD:6480464 |
CTD |
| G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
|
affects expression |
ISO |
13 |
85,776,077 |
85,792,977 |
RGD:6480464 |
CTD |
| G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
decreases activity |
ISO |
2 |
193,500,916 |
193,507,633 |
RGD:6480464 |
CTD |
| G |
Hspa1l |
heat shock protein 1-like |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases expression |
ISO |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
increases expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
multiple interactions |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
affects expression |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Iapp |
islet amyloid polypeptide |
|
multiple interactions |
EXP |
4 |
179,855,956 |
179,860,871 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
decreases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
multiple interactions |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Ide |
insulin degrading enzyme |
|
multiple interactions |
ISO |
1 |
241,547,869 |
241,646,052 |
RGD:6480464 |
CTD |
| G |
Ide |
insulin degrading enzyme |
|
increases expression |
ISO |
1 |
241,547,869 |
241,646,052 |
RGD:6480464 |
CTD |
| G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
multiple interactions |
ISO |
9 |
63,769,401 |
63,790,622 |
RGD:6480464 |
CTD |
| G |
Idh3a |
isocitrate dehydrogenase 3 (NAD+) alpha |
|
increases expression |
EXP |
8 |
58,135,412 |
58,156,019 |
RGD:6480464 |
CTD |
| G |
Idh3B |
isocitrate dehydrogenase 3 (NAD+) beta |
|
increases expression |
ISO |
3 |
117,892,614 |
117,897,633 |
RGD:6480464 |
CTD |
| G |
Ifi204 |
interferon activated gene 204 |
|
multiple interactions |
ISO |
13 |
89,752,997 |
89,770,167 |
RGD:6480464 |
CTD |
| G |
Ifi47 |
interferon gamma inducible protein 47 |
|
multiple interactions |
ISO |
10 |
34,197,630 |
34,205,133 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
multiple interactions |
ISO |
1 |
238,609,171 |
238,611,236 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
multiple interactions |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
multiple interactions |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
decreases expression |
EXP |
1 |
42,253,273 |
42,341,646 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
multiple interactions |
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10rb |
interleukin 10 receptor, beta |
|
multiple interactions |
ISO |
11 |
31,381,317 |
31,397,079 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
multiple interactions |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
multiple interactions |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
decreases expression |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
decreases expression |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r1 |
interleukin 1 receptor, type I |
|
decreases expression |
ISO |
9 |
39,434,910 |
39,473,552 |
RGD:6480464 |
CTD |
| G |
Il1rap |
interleukin 1 receptor accessory protein |
|
decreases expression |
ISO |
11 |
76,092,252 |
76,222,576 |
RGD:6480464 |
CTD |
| G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
multiple interactions |
ISO |
9 |
39,577,879 |
39,624,781 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
multiple interactions |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inpp5f |
inositol polyphosphate-5-phosphatase F |
|
increases expression |
ISO |
1 |
187,868,447 |
187,948,236 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
decreases expression |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
decreases secretion |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
increases response to substance |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
decreases expression |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
increases response to substance |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
multiple interactions |
ISO |
16 |
83,379,987 |
83,404,220 |
RGD:6480464 |
CTD |
| G |
Itga5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
increases expression |
ISO |
7 |
142,254,256 |
142,277,464 |
RGD:6480464 |
CTD |
| G |
Itga5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
multiple interactions |
ISO |
7 |
142,254,256 |
142,277,464 |
RGD:6480464 |
CTD |
| G |
Itgae |
integrin, alpha E |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgav |
integrin, alpha V |
|
multiple interactions |
ISO |
3 |
66,953,403 |
67,029,774 |
RGD:6480464 |
CTD |
| G |
Ivd |
isovaleryl-CoA dehydrogenase |
|
decreases expression |
ISO |
3 |
105,374,429 |
105,394,861 |
RGD:6480464 |
CTD |
| G |
Kifc2 |
kinesin family member C2 |
|
decreases expression |
ISO |
7 |
114,710,367 |
114,717,778 |
RGD:6480464 |
CTD |
| G |
Kitlg |
KIT ligand |
|
multiple interactions |
ISO |
7 |
37,714,157 |
37,795,722 |
RGD:6480464 |
CTD |
| G |
Klf2 |
Kruppel-like factor 2 (lung) |
|
multiple interactions |
ISO |
16 |
17,941,780 |
17,943,730 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf5 |
Kruppel-like factor 5 |
|
multiple interactions |
ISO |
15 |
83,103,177 |
83,118,363 |
RGD:6480464 |
CTD |
| G |
Lair1 |
leukocyte-associated immunoglobulin-like receptor 1 |
|
increases expression |
ISO |
1 |
69,571,996 |
69,601,974 |
RGD:6480464 |
CTD |
| G |
Lamb1 |
laminin, beta 1 |
|
multiple interactions |
ISO |
6 |
49,115,671 |
49,183,374 |
RGD:6480464 |
CTD |
| G |
Lamp1 |
lysosomal-associated membrane protein 1 |
|
increases expression |
ISO |
16 |
81,213,165 |
81,230,019 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
multiple interactions |
ISO |
3 |
149,016,605 |
149,043,530 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
multiple interactions |
ISO |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
increases expression |
EXP |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Ldhb |
lactate dehydrogenase B |
|
multiple interactions |
ISO |
4 |
180,061,567 |
180,079,473 |
RGD:6480464 |
CTD |
| G |
Ldhb |
lactate dehydrogenase B |
|
affects expression |
ISO |
4 |
180,061,567 |
180,079,473 |
RGD:6480464 |
CTD |
| G |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
|
increases expression |
ISO |
18 |
64,755,404 |
64,788,816 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
multiple interactions |
ISO |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
multiple interactions |
ISO |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
increases expression |
ISO |
2 |
56,426,058 |
56,477,198 |
RGD:6480464 |
CTD |
| G |
Lipa |
lipase A, lysosomal acid, cholesterol esterase |
|
multiple interactions |
ISO |
1 |
238,466,493 |
238,500,195 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
increases expression |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
multiple interactions |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Litaf |
lipopolysaccharide-induced TNF factor |
|
multiple interactions |
ISO |
10 |
4,614,177 |
4,623,903 |
RGD:6480464 |
CTD |
| G |
LOC100302372 |
hypothetical protein LOC100302372 |
|
decreases expression |
ISO |
13 |
75,458,253 |
75,495,823 |
RGD:6480464 |
CTD |
| G |
LOC100361295 |
methylmalonyl-Coenzyme A mutase |
|
increases expression |
ISO |
9 |
15,768,911 |
15,797,489 |
RGD:6480464 |
CTD |
| G |
LOC100363268 |
rCG31129-like |
|
affects expression |
ISO |
2 |
189,674,857 |
189,675,177 |
RGD:6480464 |
CTD |
| G |
LOC500300 |
similar to hypothetical protein MGC6835 |
|
multiple interactions |
ISO |
4 |
153,000,782 |
153,002,562 |
RGD:6480464 |
CTD |
| G |
LOC691931 |
hypothetical protein LOC691931 |
|
decreases expression |
ISO |
2 |
225,153,751 |
225,184,430 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
decreases expression |
EXP |
6 |
40,253,664 |
40,297,195 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
increases response to substance |
ISO |
6 |
40,253,664 |
40,297,195 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
multiple interactions |
ISO |
6 |
40,253,664 |
40,297,195 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
increases expression |
EXP |
6 |
40,253,664 |
40,297,195 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
affects expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
|
multiple interactions |
ISO |
7 |
67,520,575 |
67,601,549 |
RGD:6480464 |
CTD |
| G |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
|
increases activity |
ISO |
7 |
67,520,575 |
67,601,549 |
RGD:6480464 |
CTD |
| G |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
|
increases expression |
ISO |
7 |
67,520,575 |
67,601,549 |
RGD:6480464 |
CTD |
| G |
Lrp11 |
low density lipoprotein receptor-related protein 11 |
|
decreases expression |
ISO |
1 |
2,255,892 |
2,284,328 |
RGD:6480464 |
CTD |
| G |
Ly6c |
Ly6-C antigen |
|
increases expression |
EXP |
7 |
113,179,070 |
113,182,136 |
RGD:6480464 |
CTD |
| G |
Lyrm1 |
LYR motif containing 1 |
|
decreases expression |
ISO |
1 |
178,216,553 |
178,265,367 |
RGD:6480464 |
CTD |
| G |
Man1c1 |
mannosidase, alpha, class 1C, member 1 |
|
decreases expression |
ISO |
5 |
153,318,031 |
153,459,786 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
multiple interactions |
EXP |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
|
decreases expression |
ISO |
5 |
151,873,619 |
151,885,483 |
RGD:6480464 |
CTD |
| G |
Map4k1 |
mitogen activated protein kinase kinase kinase kinase 1 |
|
decreases expression |
ISO |
1 |
84,094,589 |
84,116,015 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases activity |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases activity |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk4 |
mitogen-activated protein kinase 4 |
|
multiple interactions |
ISO |
18 |
70,707,645 |
70,755,517 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
multiple interactions |
ISO |
20 |
41,304,058 |
41,310,104 |
RGD:6480464 |
CTD |
| G |
Mb21d2 |
Mab-21 domain containing 2 |
|
multiple interactions |
ISO |
11 |
73,733,241 |
73,831,764 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
multiple interactions |
EXP |
18 |
78,943,608 |
79,057,329 |
RGD:6480464 |
CTD |
| G |
Mccc1 |
methylcrotonoyl-CoA carboxylase 1 (alpha) |
|
decreases expression |
ISO |
2 |
122,416,660 |
122,469,557 |
RGD:6480464 |
CTD |
| G |
Mdh2 |
malate dehydrogenase 2, NAD (mitochondrial) |
|
increases expression |
ISO |
12 |
22,021,302 |
22,034,257 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
increases expression |
EXP |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Metrn |
meteorin, glial cell differentiation regulator |
|
decreases expression |
ISO |
10 |
15,062,082 |
15,064,100 |
RGD:6480464 |
CTD |
| G |
Mfap5 |
microfibrillar associated protein 5 |
|
multiple interactions |
ISO |
4 |
158,959,286 |
158,981,967 |
RGD:6480464 |
CTD |
| G |
Mgat4c |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
|
decreases expression |
ISO |
7 |
40,171,454 |
40,383,441 |
RGD:6480464 |
CTD |
| G |
Mgll |
monoglyceride lipase |
|
multiple interactions |
ISO |
4 |
122,822,493 |
122,922,892 |
RGD:6480464 |
CTD |
| G |
Mgll |
monoglyceride lipase |
|
increases expression |
EXP |
4 |
122,822,493 |
122,922,892 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
multiple interactions |
ISO |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
affects expression |
ISO |
13 |
83,038,049 |
83,058,802 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
decreases expression |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mmp16 |
matrix metallopeptidase 16 |
|
multiple interactions |
ISO |
5 |
32,352,311 |
32,586,469 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases activity |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases secretion |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mog |
myelin oligodendrocyte glycoprotein |
|
multiple interactions |
EXP |
20 |
1,601,731 |
1,611,963 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mrps36 |
mitochondrial ribosomal protein S36 |
|
affects expression |
ISO |
2 |
31,530,724 |
31,538,504 |
RGD:6480464 |
CTD |
| G |
Msmo1 |
methylsterol monooxygenase 1 |
|
multiple interactions |
ISO |
16 |
26,698,324 |
26,716,247 |
RGD:6480464 |
CTD |
| G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
|
increases expression |
ISO |
MT |
7,006 |
7,689 |
RGD:6480464 |
CTD |
| G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
|
increases expression |
ISO |
MT |
7,006 |
7,689 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects response to substance |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
increases phosphorylation |
EXP |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mut |
methylmalonyl CoA mutase |
|
increases expression |
ISO |
9 |
16,065,495 |
16,093,956 |
RGD:6480464 |
CTD |
| G |
Mxd1 |
max dimerization protein 1 |
|
multiple interactions |
ISO |
4 |
120,801,932 |
120,822,346 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myh7 |
myosin, heavy chain 7, cardiac muscle, beta |
|
increases expression |
EXP |
15 |
33,072,928 |
33,094,595 |
RGD:6480464 |
CTD |
| G |
Myl7 |
myosin, light chain 7, regulatory |
|
increases expression |
EXP |
14 |
86,568,142 |
86,570,122 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
multiple interactions |
ISO |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
multiple interactions |
ISO |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
decreases expression |
ISO |
13 |
67,806,516 |
67,834,105 |
RGD:6480464 |
CTD |
| G |
Ndn |
necdin, melanoma antigen (MAGE) family member |
|
increases expression |
ISO |
1 |
116,594,603 |
116,596,202 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
multiple interactions |
ISO |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
decreases expression |
ISO |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Ndufa11 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ndufa5 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 |
|
increases expression |
ISO |
4 |
50,649,500 |
50,657,858 |
RGD:6480464 |
CTD |
| G |
Ndufa7l |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7-like |
|
affects expression |
ISO |
3 |
55,312,099 |
55,312,440 |
RGD:6480464 |
CTD |
| G |
Ndufb3l |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3-like |
|
affects expression |
ISO |
4 |
99,049,726 |
99,050,028 |
RGD:6480464 |
CTD |
| G |
Ndufb4 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 4 |
|
affects expression |
ISO |
11 |
64,852,589 |
64,859,550 |
RGD:6480464 |
CTD |
| G |
Nfatc2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
|
affects response to substance |
ISO |
3 |
159,656,032 |
159,773,643 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases phosphorylation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nid1 |
nidogen 1 |
|
increases expression |
EXP |
17 |
66,857,529 |
66,930,273 |
RGD:6480464 |
CTD |
| G |
Nid2 |
nidogen 2 (osteonidogen) |
|
multiple interactions |
ISO |
15 |
4,801,183 |
4,856,895 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases phosphorylation |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
multiple interactions |
ISO |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
multiple interactions |
ISO |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases expression |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases expression |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppb |
natriuretic peptide B |
|
increases expression |
EXP |
5 |
165,062,348 |
165,063,650 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
multiple interactions |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
increases expression |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
affects localization |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nrip1 |
nuclear receptor interacting protein 1 |
|
increases expression |
ISO |
11 |
15,066,443 |
15,150,137 |
RGD:6480464 |
CTD |
| G |
Nsdhl |
NAD(P) dependent steroid dehydrogenase-like |
|
affects expression |
ISO |
X |
158,923,025 |
158,954,914 |
RGD:6480464 |
CTD |
| G |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
|
decreases expression |
ISO |
19 |
44,181,782 |
44,196,976 |
RGD:6480464 |
CTD |
| G |
Ogn |
osteoglycin |
|
multiple interactions |
ISO |
17 |
20,987,029 |
21,007,525 |
RGD:6480464 |
CTD |
| G |
Olr1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
increases expression |
ISO |
4 |
166,747,228 |
166,769,340 |
RGD:6480464 |
CTD |
| G |
Oma1 |
zinc metallopeptidase homolog (S. cerevisiae) |
|
increases expression |
ISO |
5 |
124,261,197 |
124,314,715 |
RGD:6480464 |
CTD |
| G |
Omd |
osteomodulin |
|
multiple interactions |
ISO |
17 |
21,015,178 |
21,023,126 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
multiple interactions |
ISO |
5 |
80,325,042 |
80,328,194 |
RGD:6480464 |
CTD |
| G |
Pald1 |
phosphatase domain containing, paladin 1 |
|
decreases expression |
ISO |
20 |
28,682,111 |
28,718,682 |
RGD:6480464 |
CTD |
| G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
|
increases expression |
ISO |
1 |
236,592,414 |
236,677,379 |
RGD:6480464 |
CTD |
| G |
Pc |
pyruvate carboxylase |
|
multiple interactions |
ISO |
1 |
207,112,853 |
207,212,737 |
RGD:6480464 |
CTD |
| G |
Pc |
pyruvate carboxylase |
|
increases expression |
ISO |
1 |
207,112,853 |
207,212,737 |
RGD:6480464 |
CTD |
| G |
Pcdh7 |
protocadherin 7 |
|
multiple interactions |
ISO |
14 |
56,609,036 |
57,323,892 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases activity |
ISO |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
ISO |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
multiple interactions |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
|
affects expression |
ISO |
15 |
33,671,834 |
33,680,613 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
decreases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdha1 |
pyruvate dehydrogenase (lipoamide) alpha 1 |
|
decreases expression |
EXP |
X |
55,899,491 |
55,913,319 |
RGD:6480464 |
CTD |
| G |
Pdha1 |
pyruvate dehydrogenase (lipoamide) alpha 1 |
|
increases expression |
ISO |
X |
55,899,491 |
55,913,319 |
RGD:6480464 |
CTD |
| G |
Pdha1 |
pyruvate dehydrogenase (lipoamide) alpha 1 |
|
increases expression |
EXP |
X |
55,899,491 |
55,913,319 |
RGD:6480464 |
CTD |
| G |
Pdhb |
pyruvate dehydrogenase (lipoamide) beta |
|
increases expression |
ISO |
15 |
18,737,449 |
18,743,391 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
multiple interactions |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdlim2 |
PDZ and LIM domain 2 |
|
decreases expression |
ISO |
15 |
50,564,108 |
50,575,871 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
decreases expression |
ISO |
10 |
96,056,220 |
96,057,232 |
RGD:6480464 |
CTD |
| G |
Per1 |
period circadian clock 1 |
|
multiple interactions |
ISO |
10 |
55,859,851 |
55,868,747 |
RGD:6480464 |
CTD |
| G |
Pfkm |
phosphofructokinase, muscle |
|
decreases expression |
EXP |
7 |
136,826,122 |
136,846,040 |
RGD:6480464 |
CTD |
| G |
Pfkm |
phosphofructokinase, muscle |
|
affects expression |
ISO |
7 |
136,826,122 |
136,846,040 |
RGD:6480464 |
CTD |
| G |
Phlda2 |
pleckstrin homology-like domain, family A, member 2 |
|
decreases expression |
ISO |
1 |
203,878,093 |
203,879,038 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
affects expression |
ISO |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
multiple interactions |
EXP |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
multiple interactions |
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plbd1 |
phospholipase B domain containing 1 |
|
increases expression |
ISO |
4 |
173,611,465 |
173,667,759 |
RGD:6480464 |
CTD |
| G |
Plin1 |
perilipin 1 |
|
affects response to substance |
ISO |
1 |
135,497,431 |
135,509,926 |
RGD:6480464 |
CTD |
| G |
Plin2 |
perilipin 2 |
|
multiple interactions |
ISO |
5 |
105,718,496 |
105,732,817 |
RGD:6480464 |
CTD |
| G |
Plin2 |
perilipin 2 |
|
multiple interactions |
EXP |
5 |
105,718,496 |
105,732,817 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
multiple interactions |
ISO |
2 |
41,800,745 |
41,806,503 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
multiple interactions |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Plxna2 |
plexin A2 |
|
multiple interactions |
ISO |
13 |
110,555,958 |
110,754,672 |
RGD:6480464 |
CTD |
| G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
|
multiple interactions |
ISO |
1 |
201,641,939 |
201,647,021 |
RGD:6480464 |
CTD |
| G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
|
increases expression |
ISO |
1 |
201,641,939 |
201,647,021 |
RGD:6480464 |
CTD |
| G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
|
increases expression |
ISO |
1 |
201,641,939 |
201,647,021 |
RGD:6480464 |
CTD |
| G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
|
multiple interactions |
ISO |
1 |
201,641,939 |
201,647,021 |
RGD:6480464 |
CTD |
| G |
Pon2 |
paraoxonase 2 |
|
decreases expression |
ISO |
4 |
30,033,229 |
30,068,643 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
multiple interactions |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Ppap2b |
phosphatidic acid phosphatase type 2B |
|
increases expression |
ISO |
5 |
126,121,416 |
126,197,099 |
RGD:6480464 |
CTD |
| G |
Ppap2b |
phosphatidic acid phosphatase type 2B |
|
decreases expression |
ISO |
5 |
126,121,416 |
126,197,099 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
affects expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
affects binding |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
affects binding |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
affects response to substance |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
affects response to substance |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
affects localization |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
EXP |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
affects response to substance |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
EXP |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
EXP |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Pram1 |
PML-RARA regulated adaptor molecule 1 |
|
increases expression |
ISO |
7 |
16,143,455 |
16,149,438 |
RGD:6480464 |
CTD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
multiple interactions |
ISO |
2 |
54,327,821 |
54,360,462 |
RGD:6480464 |
CTD |
| G |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
|
multiple interactions |
EXP |
5 |
126,007,672 |
126,074,012 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
multiple interactions |
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
affects response to substance |
ISO |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases expression |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
affects response to substance |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases expression |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases expression |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Ptges2 |
prostaglandin E synthase 2 |
|
affects expression |
ISO |
3 |
11,521,214 |
11,528,395 |
RGD:6480464 |
CTD |
| G |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
|
multiple interactions |
ISO |
3 |
158,356,878 |
158,387,984 |
RGD:6480464 |
CTD |
| G |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
|
affects expression |
ISO |
3 |
158,356,878 |
158,387,984 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
protein tyrosine kinase 2 |
|
decreases phosphorylation |
ISO |
7 |
110,933,298 |
111,084,554 |
RGD:6480464 |
CTD |
| G |
Ptp4a1 |
protein tyrosine phosphatase type IVA, member 1 |
|
multiple interactions |
ISO |
9 |
29,617,636 |
29,625,197 |
RGD:6480464 |
CTD |
| G |
Pygm |
phosphorylase, glycogen, muscle |
|
decreases activity |
EXP |
1 |
209,166,701 |
209,181,588 |
RGD:6480464 |
CTD |
| G |
Pygm |
phosphorylase, glycogen, muscle |
|
decreases expression |
EXP |
1 |
209,166,701 |
209,181,588 |
RGD:6480464 |
CTD |
| G |
Qprt |
quinolinate phosphoribosyltransferase |
|
decreases expression |
ISO |
1 |
186,358,523 |
186,374,681 |
RGD:6480464 |
CTD |
| G |
Rab15 |
RAB15, member RAS oncogene family |
|
decreases expression |
ISO |
6 |
99,378,937 |
99,403,340 |
RGD:6480464 |
CTD |
| G |
Rab1b |
RAB1B, member RAS oncogene family |
|
increases expression |
ISO |
1 |
207,720,833 |
207,727,458 |
RGD:6480464 |
CTD |
| G |
Rab20 |
RAB20, member RAS oncogene family |
|
increases expression |
ISO |
16 |
82,871,002 |
82,895,146 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
multiple interactions |
ISO |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Ranbp2 |
RAN binding protein 2 |
|
multiple interactions |
ISO |
20 |
37,271,467 |
37,322,723 |
RGD:6480464 |
CTD |
| G |
Rap1gap |
Rap1 GTPase-activating protein |
|
decreases expression |
ISO |
5 |
156,468,558 |
156,489,592 |
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rasa3 |
RAS p21 protein activator 3 |
|
multiple interactions |
ISO |
16 |
80,710,463 |
80,824,220 |
RGD:6480464 |
CTD |
| G |
Rasa3 |
RAS p21 protein activator 3 |
|
multiple interactions |
ISO |
16 |
80,710,463 |
80,824,220 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases phosphorylation |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
increases phosphorylation |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbks |
ribokinase |
|
increases expression |
ISO |
6 |
24,792,303 |
24,868,759 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
increases expression |
ISO |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
Rdh10 |
retinol dehydrogenase 10 (all-trans) |
|
increases expression |
ISO |
5 |
2,286,373 |
2,314,154 |
RGD:6480464 |
CTD |
| G |
Reep3 |
receptor accessory protein 3 |
|
multiple interactions |
ISO |
20 |
22,314,093 |
22,397,087 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects localization |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases expression |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Reps2 |
RALBP1 associated Eps domain containing 2 |
|
decreases expression |
ISO |
X |
52,808,111 |
53,083,646 |
RGD:6480464 |
CTD |
| G |
Retsat |
retinol saturase (all trans retinol 13,14 reductase) |
|
increases expression |
ISO |
4 |
106,100,103 |
106,108,866 |
RGD:6480464 |
CTD |
| G |
Rfxap |
regulatory factor X-associated protein |
|
decreases expression |
ISO |
2 |
144,036,652 |
144,040,835 |
RGD:6480464 |
CTD |
| G |
RGD1307704 |
similar to RIKEN cDNA 2410016O06 |
|
multiple interactions |
ISO |
6 |
107,985,351 |
107,987,969 |
RGD:6480464 |
CTD |
| G |
RGD1309821 |
similar to KIAA1161 protein |
|
decreases expression |
ISO |
5 |
58,917,805 |
58,923,251 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
multiple interactions |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhobtb3 |
Rho-related BTB domain containing 3 |
|
increases expression |
ISO |
2 |
2,911,820 |
2,967,473 |
RGD:6480464 |
CTD |
| G |
Rictor |
RPTOR independent companion of MTOR, complex 2 |
|
multiple interactions |
ISO |
2 |
55,982,784 |
56,071,528 |
RGD:6480464 |
CTD |
| G |
Rorc |
RAR-related orphan receptor C |
|
increases expression |
ISO |
2 |
189,345,134 |
189,369,442 |
RGD:6480464 |
CTD |
| G |
Rpia |
ribose 5-phosphate isomerase A |
|
increases expression |
ISO |
4 |
103,934,938 |
103,960,574 |
RGD:6480464 |
CTD |
| G |
Rps27a |
ribosomal protein S27a |
|
affects expression |
ISO |
14 |
110,559,621 |
110,561,451 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
increases phosphorylation |
EXP |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6ka4 |
ribosomal protein S6 kinase, polypeptide 4 |
|
multiple interactions |
ISO |
1 |
209,505,327 |
209,516,071 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
increases phosphorylation |
EXP |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rpusd2 |
RNA pseudouridylate synthase domain containing 2 |
|
multiple interactions |
ISO |
3 |
105,542,274 |
105,547,523 |
RGD:6480464 |
CTD |
| G |
Rras |
related RAS viral (r-ras) oncogene homolog |
|
multiple interactions |
ISO |
1 |
95,490,730 |
95,495,462 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
decreases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
decreases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
increases expression |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
multiple interactions |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
increases expression |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
increases expression |
ISO |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
increases expression |
EXP |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
decreases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scp2 |
sterol carrier protein 2 |
|
affects expression |
ISO |
5 |
129,152,836 |
129,230,401 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
multiple interactions |
ISO |
7 |
68,290,558 |
68,405,183 |
RGD:6480464 |
CTD |
| G |
Sdhd |
succinate dehydrogenase complex, subunit D, integral membrane protein |
|
increases expression |
ISO |
8 |
53,955,067 |
53,964,547 |
RGD:6480464 |
CTD |
| G |
Sele |
selectin E |
|
decreases expression |
ISO |
13 |
79,813,455 |
79,822,845 |
RGD:6480464 |
CTD |
| G |
Selplg |
selectin P ligand |
|
decreases expression |
ISO |
12 |
43,842,268 |
43,843,560 |
RGD:6480464 |
CTD |
| G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
multiple interactions |
ISO |
6 |
128,461,775 |
128,469,309 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serping1 |
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
|
multiple interactions |
ISO |
3 |
67,968,808 |
67,978,102 |
RGD:6480464 |
CTD |
| G |
Sesn1 |
sestrin 1 |
|
multiple interactions |
ISO |
20 |
45,786,623 |
45,877,856 |
RGD:6480464 |
CTD |
| G |
Sesn1 |
sestrin 1 |
|
increases expression |
ISO |
20 |
45,786,623 |
45,877,856 |
RGD:6480464 |
CTD |
| G |
Sfrp1 |
secreted frizzled-related protein 1 |
|
multiple interactions |
ISO |
16 |
73,030,458 |
73,067,304 |
RGD:6480464 |
CTD |
| G |
Sfrp2 |
secreted frizzled-related protein 2 |
|
multiple interactions |
ISO |
2 |
175,479,320 |
175,486,865 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
multiple interactions |
EXP |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Siglech |
sialic acid binding Ig-like lectin H |
|
increases expression |
ISO |
1 |
107,126,060 |
107,130,290 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt6 |
sirtuin 6 |
|
multiple interactions |
EXP |
7 |
9,555,269 |
9,560,695 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 1 |
|
multiple interactions |
EXP |
3 |
112,455,897 |
112,534,752 |
RGD:6480464 |
CTD |
| G |
Slc12a2 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
multiple interactions |
ISO |
18 |
53,673,215 |
53,741,352 |
RGD:6480464 |
CTD |
| G |
Slc12a2 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
decreases expression |
ISO |
18 |
53,673,215 |
53,741,352 |
RGD:6480464 |
CTD |
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
multiple interactions |
ISO |
15 |
106,549,586 |
106,592,594 |
RGD:6480464 |
CTD |
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
multiple interactions |
ISO |
15 |
106,549,586 |
106,592,594 |
RGD:6480464 |
CTD |
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
increases activity |
ISO |
15 |
106,549,586 |
106,592,594 |
RGD:6480464 |
CTD |
| G |
Slc25a20 |
solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
|
increases expression |
ISO |
8 |
113,715,211 |
113,737,063 |
RGD:6480464 |
CTD |
| G |
Slc26a11 |
solute carrier family 26, member 11 |
|
increases expression |
ISO |
10 |
108,730,993 |
108,741,761 |
RGD:6480464 |
CTD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
decreases expression |
ISO |
16 |
18,769,909 |
18,786,988 |
RGD:6480464 |
CTD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
increases expression |
ISO |
16 |
18,769,909 |
18,786,988 |
RGD:6480464 |
CTD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
multiple interactions |
ISO |
16 |
18,769,909 |
18,786,988 |
RGD:6480464 |
CTD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
multiple interactions |
ISO |
4 |
159,210,116 |
159,221,169 |
RGD:6480464 |
CTD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
increases expression |
EXP |
4 |
159,210,116 |
159,221,169 |
RGD:6480464 |
CTD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
increases expression |
EXP |
4 |
159,210,116 |
159,221,169 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases expression |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc4a4 |
solute carrier family 4, sodium bicarbonate cotransporter, member 4 |
|
multiple interactions |
ISO |
14 |
20,381,545 |
20,739,216 |
RGD:6480464 |
CTD |
| G |
Slitrk4 |
SLIT and NTRK-like family, member 4 |
|
increases expression |
ISO |
X |
150,053,376 |
150,059,675 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
multiple interactions |
ISO |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Snai3 |
snail homolog 3 (Drosophila) |
|
increases expression |
ISO |
19 |
52,742,687 |
52,749,406 |
RGD:6480464 |
CTD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
multiple interactions |
EXP |
10 |
107,958,468 |
107,959,330 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases activity |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
multiple interactions |
ISO |
14 |
63,381,447 |
63,387,180 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
decreases expression |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
increases expression |
EXP |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
multiple interactions |
ISO |
10 |
106,641,509 |
106,645,579 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
|
multiple interactions |
ISO |
3 |
8,956,380 |
9,021,831 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
multiple interactions |
ISO |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Ssmem1 |
serine-rich single-pass membrane protein 1 |
|
decreases expression |
ISO |
4 |
57,419,710 |
57,429,788 |
RGD:6480464 |
CTD |
| G |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
|
multiple interactions |
ISO |
7 |
104,467,678 |
104,474,345 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
EXP |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
EXP |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stk11 |
serine/threonine kinase 11 |
|
multiple interactions |
EXP |
7 |
11,086,760 |
11,103,522 |
RGD:6480464 |
CTD |
| G |
Stk11 |
serine/threonine kinase 11 |
|
increases phosphorylation |
EXP |
7 |
11,086,760 |
11,103,522 |
RGD:6480464 |
CTD |
| G |
Stub1 |
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
|
decreases expression |
EXP |
10 |
15,096,150 |
15,098,431 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
multiple interactions |
ISO |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
increases expression |
EXP |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Tacstd2 |
tumor-associated calcium signal transducer 2 |
|
decreases expression |
ISO |
4 |
97,803,151 |
97,804,851 |
RGD:6480464 |
CTD |
| G |
Tagln |
transgelin |
|
multiple interactions |
ISO |
8 |
48,902,208 |
48,907,682 |
RGD:6480464 |
CTD |
| G |
Taldo1 |
transaldolase 1 |
|
increases expression |
ISO |
1 |
201,582,856 |
201,593,187 |
RGD:6480464 |
CTD |
| G |
Tbc1d2 |
TBC1 domain family, member 2 |
|
increases expression |
ISO |
5 |
63,177,831 |
63,225,245 |
RGD:6480464 |
CTD |
| G |
Tbl1x |
transducin (beta)-like 1 X-linked |
|
decreases expression |
ISO |
X |
63,310,560 |
63,392,534 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
multiple interactions |
ISO |
7 |
9,867,739 |
9,872,536 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
decreases expression |
ISO |
7 |
9,867,739 |
9,872,536 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
decreases activity |
ISO |
7 |
9,867,739 |
9,872,536 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
decreases expression |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
decreases expression |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
multiple interactions |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Thbs2 |
thrombospondin 2 |
|
multiple interactions |
ISO |
1 |
53,584,406 |
53,613,652 |
RGD:6480464 |
CTD |
| G |
Timm8a1 |
translocase of inner mitochondrial membrane 8 homolog a1 (yeast) |
|
affects expression |
ISO |
X |
121,993,810 |
121,997,685 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
multiple interactions |
ISO |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
multiple interactions |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
multiple interactions |
EXP |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tmem14a |
transmembrane protein 14A |
|
decreases expression |
ISO |
9 |
19,986,826 |
19,999,299 |
RGD:6480464 |
CTD |
| G |
Tmem177 |
transmembrane protein 177 |
|
multiple interactions |
ISO |
13 |
32,688,858 |
32,692,283 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
multiple interactions |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfsf12 |
tumor necrosis factor ligand superfamily member 12 |
|
decreases expression |
ISO |
10 |
56,503,756 |
56,513,053 |
RGD:6480464 |
CTD |
| G |
Tob1 |
transducer of ErbB-2.1 |
|
multiple interactions |
ISO |
10 |
82,852,405 |
82,854,443 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
increases expression |
ISO |
4 |
160,933,341 |
160,936,871 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
multiple interactions |
ISO |
8 |
71,331,304 |
71,358,063 |
RGD:6480464 |
CTD |
| G |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
|
multiple interactions |
EXP |
1 |
222,363,324 |
222,502,191 |
RGD:6480464 |
CTD |
| G |
Tuba1a |
tubulin, alpha 1A |
|
multiple interactions |
ISO |
7 |
137,729,405 |
137,733,071 |
RGD:6480464 |
CTD |
| G |
Tubb2a |
tubulin, beta 2A class IIa |
|
multiple interactions |
ISO |
17 |
37,139,177 |
37,143,049 |
RGD:6480464 |
CTD |
| G |
Tubb3 |
tubulin, beta 3 class III |
|
multiple interactions |
ISO |
19 |
53,742,652 |
53,751,706 |
RGD:6480464 |
CTD |
| G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
multiple interactions |
ISO |
19 |
26,527,548 |
26,535,621 |
RGD:6480464 |
CTD |
| G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
decreases expression |
ISO |
19 |
26,527,548 |
26,535,621 |
RGD:6480464 |
CTD |
| G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
increases expression |
ISO |
19 |
26,527,548 |
26,535,621 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
increases expression |
ISO |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
multiple interactions |
ISO |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
increases expression |
EXP |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ugp2 |
UDP-glucose pyrophosphorylase 2 |
|
decreases expression |
EXP |
14 |
102,072,724 |
102,113,561 |
RGD:6480464 |
CTD |
| G |
Ugp2 |
UDP-glucose pyrophosphorylase 2 |
|
increases expression |
EXP |
14 |
102,072,724 |
102,113,561 |
RGD:6480464 |
CTD |
| G |
Umps |
uridine monophosphate synthetase |
|
multiple interactions |
ISO |
11 |
68,619,835 |
68,630,244 |
RGD:6480464 |
CTD |
| G |
Uqcrb |
ubiquinol-cytochrome c reductase binding protein |
|
affects expression |
ISO |
7 |
67,958,363 |
67,963,730 |
RGD:6480464 |
CTD |
| G |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
|
affects expression |
ISO |
5 |
136,255,481 |
136,263,676 |
RGD:6480464 |
CTD |
| G |
Vasn |
vasorin |
|
multiple interactions |
ISO |
10 |
11,047,084 |
11,057,591 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcan |
versican |
|
multiple interactions |
ISO |
2 |
19,712,629 |
19,801,443 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vldlr |
very low density lipoprotein receptor |
|
multiple interactions |
ISO |
1 |
230,666,736 |
230,697,748 |
RGD:6480464 |
CTD |
| G |
Vldlr |
very low density lipoprotein receptor |
|
increases expression |
ISO |
1 |
230,666,736 |
230,697,748 |
RGD:6480464 |
CTD |
| G |
Wfs1 |
Wolfram syndrome 1 (wolframin) |
|
increases expression |
ISO |
14 |
79,379,680 |
79,404,003 |
RGD:6480464 |
CTD |
| G |
Wisp2 |
WNT1 inducible signaling pathway protein 2 |
|
multiple interactions |
ISO |
3 |
154,748,977 |
154,760,324 |
RGD:6480464 |
CTD |
| G |
Wnt10b |
wingless-type MMTV integration site family, member 10B |
|
decreases expression |
ISO |
7 |
137,541,197 |
137,547,000 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
increases activity |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
increases activity |
EXP |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
decreases expression |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
multiple interactions |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
decreases expression |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
multiple interactions |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Ywhah |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
|
multiple interactions |
ISO |
14 |
83,448,395 |
83,457,778 |
RGD:6480464 |
CTD |
| G |
Zbtb7b |
zinc finger and BTB domain containing 7B |
|
decreases expression |
ISO |
2 |
181,576,165 |
181,578,156 |
RGD:6480464 |
CTD |
| G |
Zc3h11a |
zinc finger CCCH-type containing 11A |
|
multiple interactions |
ISO |
13 |
46,546,434 |
46,585,149 |
RGD:6480464 |
CTD |
| G |
Zfp36 |
zinc finger protein 36 |
|
multiple interactions |
ISO |
1 |
83,486,643 |
83,489,123 |
RGD:6480464 |
CTD |
Term paths to the root
|